Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients

Thorax

Volumn 52, Issue 1, 1997, Pages 55-58

  Clark, D J ^a   Lipworth, B J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

adrenal suppression; asthma; budesonide; chronic dosing; fluticasone propionate; inhaled corticosteroids

Indexed keywords

BUDESONIDE; CREATININE; FLUTICASONE PROPIONATE; HYDROCORTISONE; PLACEBO;

ADRENAL SUPPRESSION; ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; HYDROCORTISONE BLOOD LEVEL; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031024832     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.1.55     Document Type: Article

References (14)

1. British Thoracic Society. Guidelines for management of asthma: a summary. BMJ 1993;306:776-82.
2. Clark DJ, Grove A, Cargill RI, Lipworth BJ. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Thorax 1996;51:262-6.
3. English AF, Neate MS, Quint DJ, Sareen M. Biological activities of some corticosteroids used in asthma. Am J Respir Crit Care Med 1994;149(Suppl):A212.
4. Hogger P, Rohdewald P. Binding kinetics of fluticasone propionate to the human glucocorticoid receptor. Steroids 1994;59:597-602.
5. Thorsson L, Dahlstrom K, Edsbacker S, Callen E, Poulson G, Wirren G. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects. Br J Clin Pharmacol 1997 (in press).
6. Thorrson L, Edsbacker S, Conradson TB. Lung deposition of budesonide from Turbuhaler is twice that from pressurised metered-dose inhaler. Eur Respir J 1994;7:1839-44.
7. Wurthwein G, Rehder S, Rohdewald P. Lipophilicity and receptor affinity of glucocorticoids. Pharm Zig Wiss 1992; 4:161-7.
8. Grahnen A, Eckernas SA, Brundin RM, Ling-Andersson A. An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers. Br J Clin Pharmacol 1994;38:521-5.
9. Lonnebo A, Grahnen A, Jansson B, Brundin RM, Ling-Andersson A, Eckernas SA. An assessment of the systemic effects of single and repeated doses of inhaled fluticasone propionate and inhaled budesonide in normal volunteers. Eur J Clin Pharmacol 1996;49:459-63.
10. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-43.
11. Boorsma M, Andersson N, Larsson P, Ullman A. Assessment of the relative systemic potency of inhaled Huticasone and budesonide. Eur Respir J 1996;9:1427-32.
12. Boe J, Bakke P, Rodolen T, Skovlund E, Gulsvik A. High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary adrenal (HPA) axis. Eur Respir J 1994;7:2179-84.
13. Olsson B. Aerosol particle generation from dry powder inhalers: can they equal pressurised metered dose inhalers? J Aerosol Med 1995;8(Suppl 3):s13-18.
14. McIntyre DH, Mitchell CA, Bowler SD, Armstrong JG, Wooler JA, Cowley DM. Measuring the systemic effects of inhaled beclometriasone: timed morning urine collections compared with 24 hour specimens. Thorax 1995;50:1280-4.